By Professor Gail Matthews

Book Chapters

Martinello M; Hajarizadeh B; Grebely J; Matthews G; Dore G, 2019, 'Cure and Control: What Will It Take to Eliminate HCV?', in Sofia M (ed.), HCV: The Journey from Discovery to a Cure: Volume II, Springer International Publishing, pp. 447 - 490, http://dx.doi.org/10.1007/7355_2018_56

Price V, 2014, 'HIV, viral hepatitis and STIs: a guide for primary care', in Burke M; Matthews G; Dore G; Cowie B (ed.), , Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine, Sydney, https://www.ashm.org.au/products/product/1976963411

Matthews G; Martinello MK; van Beek I; Burns M, 2014, 'Exposure and acute viral hepatitis', in HIV, Viral Hepatitis and STIs: A Guide for Primary Care

Matthews G; Dore GJ, 2009, 'HIV and hepatitis C co-infection', in Dore G; Temple-Smith M; Lloyd A (ed.), Hepatitis C: An Expanding Perspective, IP Communications, East Hawthorn, pp. 308 - 329

Journal articles

Nyein PP; Borok M; Eriobu N; Kaplan R; Kumarasamy N; Avihingsanon A; Losso MH; Azwa I; Karyana M; Dao S; Cisse M; Andrade Villanueva JF; Lupo S; Cardoso SW; Yunihastuti E; Subronto YW; Fitriah M; Katu S; Brown D; Papot E; Hutchinson J; Kelleher A; Hanson J; Dharan NJ; Petoumenos K; Matthews GV; Losso M; Solari AM; Tavella S; Cooper D; Emery S; Polizzotto M; Law M; Grinsztejn B; Wolff M; Sussmann O; Selvamuthu P; Hadi U; Soo T; Gómez JLM; Madero JS; Ann J; Mohapi L; Ploenchan ; Khusuwan S; Manosuthi W, 2026, 'A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People with HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study', Clinical Infectious Diseases, 81, pp. e568 - e580, http://dx.doi.org/10.1093/cid/ciaf346

Behrouzfar K; Han WM; Perera R; Li J; Scull KE; Howlett K; Bloch M; Baker DA; Eu B; Bowden-Reid E; Smith DE; Hoy JF; Woolley I; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Petoumenos K; Dharan NJ; Yeh P; Dawson SJ; Dawson MA; Sinclair B; Templeton DJ; O’Bryan J; Woolley I; Price S; Hoy JF; Acklom K; Lau H; Eu B; Vincent T; Han WM, 2026, 'Mosaic chromosomal alterations are suppressed in older adults with HIV', Communications Biology, 9, http://dx.doi.org/10.1038/s42003-026-10532-1

Nyein PP; Haskelberg H; Martinello M; Lowe M; Goodman-Meza D; Avihingsanon A; Kelleher AD; Rodgers A; Schutte AE; Nnakelu EC; Byakwaga H; Trevillyan J; Losso M; Kumarasamy N; Azwa RISR; Kaplan R; Clifton B; Arnott C; Dharan NJ; Petoumenos K; Matthews GV, 2026, 'Optimizing metabolic management on integrase-based ART (OPTIMAR): study protocol for a 2 × 2 factorial, randomised, double-blind placebo-controlled trial to compare the addition of dapagliflozin versus placebo, and rosuvastatin plus ezetimibe versus pitavastatin, in people with HIV on integrase strand transfer inhibitor-based antiretroviral therapy with elevated metabolic risk', Trials, 27, http://dx.doi.org/10.1186/s13063-026-09723-2

Baker JV; Siegel LK; Losso MH; Vasudeva S; Nordwall JA; Harper K; Grund B; Havens JP; Fletcher CV; Fishchuk R; Kobrynska O; Abutidze A; Metchurtchlishvili R; Ginde AA; Aggarwal NR; Poulakou G; Mourad A; Gibbs KW; Saito S; Chayakulkeeree M; Mootsikapun P; Honda H; Mateu L; Gyrina O; Garcia A; Lee DG; Casey JD; Jain MK; Bengtson CD; Hite RD; Hiranburana N; Matthay MA; Arizmendez N; Nguyen HH; Drelick A; Mena Lora AJ; Parnia S; Trautner BW; Portsmouth SD; Shimizu R; Uehara T; Paredes R; Goodman AL; Vock DM; Gelijns AC; Weintrob AC; Bajema KL; Pett SL; Lundgren J; Schechner AJ; Higgs ES; Lane HC; Matthews GV; Self WH; Reilly C, 2026, 'Ensitrelvir for the Treatment of Hospitalized Adults With COVID-19: An International Phase 3 Randomized Placebo-controlled Trial', Clinical Infectious Diseases, 83, pp. 59 - 69, http://dx.doi.org/10.1093/cid/ciag272

Lee TC; Barina LA; Walls G; Goodman AL; Yahav D; Cheng MP; Bonten M; Bowen AC; Boyles T; Daneman N; Ekkelenkamp MB; Ghanem-Zoubi N; Hensgens MPM; Jager NGL; Kaasch AJ; Kouijzer IJE; Lewis RJ; Lumley T; Lye DC; McDonald EG; McKew G; McLean ARD; McMullan BJ; McQuilten ZK; Morpeth SC; Paterson DL; Roberts JA; Robinson JO; Saito H; Scarborough M; Ten Oever J; Turner RM; Tverring J; van Hal SJ; Webb SA; Whiteway LM; Arias CA; Henderson A; Heriot GS; Snelling TL; Afra K; Ali SS; Amit S; Anagnostou NA; Archuleta S; Aston SJ; Athan E; Baharav N; Bai AD; Barber BE; Baskaran A; Berkeley MMA; Best EJ; Bhilave NR; Bloomfield MG; Bond KA; Bostock J; Botheras CL; Boyd MA; Bradshaw SME; Briggs EJ; Britton PN; Campbell AJ; Carr BZ; Chancellor JA; Chen K; Cheong EY; Chew KL; Chia PY; Chomba R; Chong BSW; Clews CJN; Cohen JM; Commons RJ; Cutfield T; Daley P; Daniel DS; Davies J; De P; Denholm JT; Di Virgilio M; Dishon-Benattar Y; Dotel R; Duan EH; Easom N; Eliakim-Raz N; England MM; Fahmy M; Findlater AR; Flanagan KL; Foo EZJ; Foo H; Forster DP; Fralick M; Frazer JL; Gador-Whyte AP; Garnham K; German GJ; Ghosh N; Gisolf EH, 2026, 'Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia', New England Journal of Medicine, 394, pp. 2329 - 2339, http://dx.doi.org/10.1056/NEJMoa2506905

Rasmussen KK; Bannister W; Itenov T; Skeans M; Pett SL; Wendt C; Kunisaki KM; Matthews G; Jordan A; Ulrik CS; Lapperre T; Bojesen RD; Bodtger U; Ilett EE; Benfield T; Sivapalan P; Murray DD; Jensen JUS, 2026, 'Severe Hospitalization-Requiring Viral Infection With Influenza or COVID-19: Metabolic Pathway Analysis', Open Forum Infectious Diseases, 13, http://dx.doi.org/10.1093/ofid/ofag316

Goyal A; Cotler SJ; Matthews GV; Page K; Kushner T; Etzion O; Martinello M; Dahari H, 2026, 'Modeling Predicts Direct-Acting Antiviral Therapy for 5-Weeks May Cure Recent or Chronic Hepatitis C Infection Among People With Undetectable Viral RNA by Day 7', Journal of Infectious Diseases, pp. jiag260, http://dx.doi.org/10.1093/infdis/jiag260

Goodman-Meza D; Martinello M; Masters J; Russell D; Jacka B; Matthews GV; Dore GJ, 2026, 'Large Language Models Accurately Identify People Who Inject Drugs From Infectious Diseases Discharge Summaries in an Australian Hospital', Drug and Alcohol Review, 45, http://dx.doi.org/10.1111/dar.70169

Conway A; Grebely J; Tillakeratne S; Cunningham EB; Munyengeterwa U; Van Dyk J; Martinello M; Carson J; Lafferty L; Bull RA; Horsburgh B; McGrath C; Brown T; Treloar C; Amin J; Degenhardt L; Applegate TL; Dunlop A; Matthews GV; Dore GJ; Lloyd AR; Hajarizadeh B, 2026, 'Reinfection following direct-acting antiviral therapy for hepatitis C infection among people in prison with recent injecting drug use: the SHARP-P study', International Journal of Drug Policy, 151, http://dx.doi.org/10.1016/j.drugpo.2026.105234

Carey DL; Ahlenstiel G; Brilot F; Brown DA; Bull R; Crowther H; Cunningham A; Davenport MP; Diamond P; Hamad N; Johnston A; Kelleher AD; Lee FJ; Matthews GV; Petoumenos K; Quichua GC; Swaminathan S; Trotman J; Turville S; Vukic S; Wong P; Sasson SC, 2026, 'Comparison of immunity-boosting regimens for COVID-19 upon initiation of immunosuppressive therapy (CIRCUIT): study protocol for a randomised, controlled clinical trial', BMJ Open, 16, pp. e115259, http://dx.doi.org/10.1136/bmjopen-2025-115259

Qian J; Stepien S; Cheng A; Shaw JE; Macartney K; Rowe SL; Thompson K; Dore GJ; Kaldor J; Newall AT; Wood J; Sparke C; O’Donnell B; Lambert SB; Matthews GV; Abbenbroek B; Liu B, 2026, 'New-onset diabetes following SARS-CoV-2 infection in the Omicron era: a matched cohort study', International Journal of Epidemiology, 55, http://dx.doi.org/10.1093/ije/dyag009

Obeng BM; Hutchinson J; Shaik A; Chetchotisakd P; Azwa I; Wulan WN; Kumarasamy N; Wolff M; Bruguera J; Losso M; Kaplan R; Diallo MS; Eriobu N; Musoro G; Kumalawati J; Badamasi A; Fitriah M; Mulya DP; Law M; Matthews G; Di Giallonardo F; Kelleher AD; Lowe M; Kee Yeung JY, 2026, 'Regional Variations of Rates and Determinants of Drug Resistance Mutations in People Failing First-line Therapy for HIV-1: A Substudy from the D2EFT Phase 3b/4 Clinical Trial', Clinical Infectious Diseases, 82, pp. e693 - e704, http://dx.doi.org/10.1093/cid/ciaf739

Hume SJ; Visvanathan K; Cheng K; Jackson K; Vogrin S; Hall SAL; Burns GS; Desmond PV; Ratnam D; Levy MT; Sawhney R; Strasser SI; Ngu MC; Sinclair M; Meredith C; Matthews G; Valaydon Z; Wong D; Littlejohn M; Holmes JA; Revill PA; Thompson AJ; Warner N, 2026, 'Anti-HBs Immune Complex Levels: A Novel Marker of Hepatitis Flare Following Nucleos(t)ide Analog Withdrawal in HBeAg-negative Chronic Hepatitis B', Journal of Infectious Diseases, 233, pp. e621 - e629, http://dx.doi.org/10.1093/infdis/jiaf569

Nyein PP; Donoghoe MW; Eriobu N; Uche B; Kaplan R; Carey D; Brown D; Kundro M; Dharan NJ; Hanson J; Petoumenos K; Matthews GV, 2026, 'Cardiometabolic impact of dolutegravir as second-line therapy: secondary analysis of a randomized controlled trial', AIDS, Publish Ahead of Print, http://dx.doi.org/10.1097/QAD.0000000000004476

Dyer CEF; Jin F; Roberts JM; Poynten IM; Cunningham PH; Carr A; Matthews GV; Grulich AE; Hillman RJ, 2026, 'Anal cancer screening in men who have sex with men living with HIV: The pilot of anal screening study (PASS)', HIV Medicine, 27, pp. 351 - 360, http://dx.doi.org/10.1111/hiv.70151

Hajarizadeh B; George J; Levy MT; Wong I; Howell J; Cabrera G; Tu E; Martinello M; Applegate TL; Matthews GV, 2026, 'Evaluation of fingerstick blood point-of-care testing of hepatitis B DNA for enhanced hepatitis B treatment decision making: a diagnostic accuracy study', Journal of Clinical Microbiology, 64, http://dx.doi.org/10.1128/jcm.01405-25

Donoghoe MW; Sazzad HMS; Han WM; Bloch M; Baker DA; Eu B; Bowden-Reid E; Smith DE; Hoy JF; Woolley IJ; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Agbosu E; Kelleher AD; Petoumenos K; Phetsouphanh C; Yeh P; Dharan NJ; Donoghoe MW; Han WM; Bloch M; Vincent T; Baker DA; Eu B; Lau H; Smith DE; Acklom K; Hoy JF; Price S; Woolley I; O’Bryan J; Finlayson R; Templeton DJ; Sinclair B; Matthews G; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Kelleher AD; Petoumenos K; Yeh P; Dharan NJ, 2026, 'Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort study', Gut, pp. gutjnl-2025-337620, http://dx.doi.org/10.1136/gutjnl-2025-337620

Hosseini-Hooshyar S; Valerio H; Flynn E; Sexton C; Barzi F; Amarasena S; De Koster L; Sellen D; Winterfield N; Grebely J; Matthews GV; Boyd MA; Applegate TL; Petoumenos K; Lafferty L; Dore GJ; Treloar C; Martinello M; Ward J, 2025, 'A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study', BMC Infectious Diseases, 25, http://dx.doi.org/10.1186/s12879-025-12004-z

Sábato S; Benet S; Rogers AJ; Murray TA; Skeans M; Mothe B; Paredes R; Mourad A; Kiweewa F; Kamel D; Jain MK; Lutaakome J; Nalubega MG; Sebudde N; Mylonakis E; Braun DL; Hatlen T; Kimuli I; Kitko C; Mugerwa H; Kitonsa J; Kim K; Tien PC; Highbarger J; McCormack AL; Sanchez A; Murray DD; Babiker AG; Davey VJ; Files DC; Gelijns AC; Higgs ES; Kan VL; Matthews GV; Pett SL; Lane HC; Reilly C; Goodman AL; Lundgren JD; Moltó J; Yeo HP; Diong SH; Ong SWX; Chia PY; Young BE; Uche B; Idoko G; Habib Z; Kwaghe V; Eriobu N; Amodeo A; de Lara CT; Grüttner-Durmaz M; West E; Günthard HF; Martí R; Martínez L; Pena AMM; Morales-Rull JL; Borras B; Otero S; Martínez X; del Amo E; Campins M; Ausín C; Gomez J; Padure S; Di Natale M; Fernández-Cruz E; Muñoz J; Roldan M; Legarda A; Balerdi L; Trilla A; Abad E; Martínez A; Badillo J; Expósito M; Theresa N; Mugerwa O; Okoth I; Nabankema E; Kisuule R; Wangi D; Nalaaki M; Lubega G; Kibirige M; Nabaggala P; Nandhego J; Naluyinda H; Tukamwesiga N; Atukunda A; Segawa I; Mbabazi Q; Kirenga B; Nantongo C; Alum PI; Nyiraguhirwa D; Apio F, 2025, 'SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)', Scientific Reports, 15, http://dx.doi.org/10.1038/s41598-025-92742-x

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Corrigendum to “Missed opportunities in HCV care: Trends in late diagnosis and treatment” (JHEP Reports (2025) 7(9), (S2589555925001521), (10.1016/j.jhepr.2025.101474))', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101561

Khanna S; Wilson D; Virk S; Bhat A; Houston L; Matthews G; Nerlekar N; Arnott C, 2025, 'Evaluation of the Clinical Significance of Carotid Plaque Characteristics in Ischaemic Stroke: A Systematic Review and Meta-Analysis', Heart Lung and Circulation, 34, pp. 1041 - 1049, http://dx.doi.org/10.1016/j.hlc.2025.08.015

Masters J; Goodman-Meza D; Russell D; Marks L; McCreary E; Jacka B; Seear K; Davis JS; Matthews G; Martinello M; Tong SYC; Dore GJ, 2025, 'Bacterial and fungal infections in persons who inject drugs', Clinical Microbiology Reviews, 38, http://dx.doi.org/10.1128/cmr.00162-23

Dharan NJ; Sharma S; Arenas-Pinto A; Duprez D; Estrada V; Ha K; Angelica Kundro M; Mngqibisa R; Mugerwa H; Munroe D; Nasreddine R; Peterson TE; Sereti I; Trevillyan JM; Baker JV; Matthews GV; Phillips AN, 2025, 'Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf561

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; Petoumenos K; George J; Amin J; Matthews GV; Grebely J; Pearson SA; Dore GJ, 2025, 'Missed opportunities in HCV care: Trends in late diagnosis and treatment', Jhep Reports, 7, http://dx.doi.org/10.1016/j.jhepr.2025.101474

Ang J; Hajarizadeh B; Tillakeratne S; Dore GJ; Treloar C; Amin J; van Dyk J; Degenhardt L; Applegate T; Dunlop A; Fraser C; Conway B; Wong A; Fuchs D; Powis J; Mason K; Gane EJ; Weltman M; Read P; Martinello M; Rowe E; Baker DA; Wade A; Matthews G; Lafferty L; Lloyd A; Grebely J; Cunningham EB, 2025, 'Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use: the SHARP-C study', International Journal of Drug Policy, 143, http://dx.doi.org/10.1016/j.drugpo.2025.104859

Jensen TO; Sharma S; Avihingsanon A; Lutaakome J; Brar I; Burman W; Chetchotisakd P; de Castro N; Galán-Herrera JF; Kumarasamy N; Paredes R; Ridzon R; Sciaudone M; Singh K; Uriel A; Lundgren J; Reilly C; Matthews G, 2025, 'Risk of severe bacterial infections including TB before and after immediate or deferred antiretroviral therapy: A multicenter, prospective, cohort study', International Journal of Infectious Diseases, 156, http://dx.doi.org/10.1016/j.ijid.2025.107911

Young J; Wang S; Sacks-Davis R; Stewart A; Van Santen DK; Van Der Valk M; Doyle JS; Matthews G; Berenguer J; Wittkop L; Lacombe K; Rauch A; Stoové M; Hellard M; Klein MB, 2025, 'Liver Fibrosis Regression in People Living With HIV After Successful Treatment for Hepatitis C', Journal of Acquired Immune Deficiency Syndromes 1999, 99, pp. 166 - 174, http://dx.doi.org/10.1097/QAI.0000000000003646

Goodman-Meza D; Weiss RE; Poimboeuf ML; Feng J; Vijayan T; Martinello M; Matthews GV; Dore GJ, 2025, 'Comparative Effectiveness of Long-Acting Lipoglycopeptides vs Standard-of-Care Antibiotics in Serious Bacterial Infections', JAMA Network Open, 8, http://dx.doi.org/10.1001/jamanetworkopen.2025.11641

Masters J; Jacka B; Barault M; Goodman-Meza D; Russell D; Matthews GV; Dore GJ; Valerio H; Martinello M, 2025, 'Incidence, Patient-Directed Discharge, Readmission, and Mortality Among People Hospitalized With Injecting-Related Infection: A Population-Based Linkage Study', Open Forum Infectious Diseases, 12, pp. ofaf257, http://dx.doi.org/10.1093/ofid/ofaf257

Jacka BP; Cheng QL; Schiavone B; Darley DR; Kelleher AD; Dore GJ; Matthews GV, 2025, 'Trajectories of Health-Related Quality of Life 2 Years After Mild/Moderate Severe Acute Respiratory Syndrome Coronavirus 2 Infection in the Pre-Omicron Era', Open Forum Infectious Diseases, 12, pp. ofaf142, http://dx.doi.org/10.1093/ofid/ofaf142

Tillakeratne S; Valerio H; Alavi M; Hajarizadeh B; Martinello M; George J; Matthews G; Grebely J; Pearson SA; Dore GJ, 2025, 'Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, Australia', International Journal of Drug Policy, 139, http://dx.doi.org/10.1016/j.drugpo.2025.104790

Nyein PP; Petoumenos K; Dharan NJ; Hanson J; Matthews GV, 2025, 'Reply to Dr Martinez: Refining Our Understanding of the Association between Integrase Inhibitor Therapy and Elevations in Blood Pressure', Clinical Infectious Diseases, 80, pp. 927, http://dx.doi.org/10.1093/cid/ciae345

Wheeler A; Masters J; Pradhan A; Roth JM; Degenhardt L; Dore GJ; Matthews GV; Cunningham EB; Peacock A; Colledge-Frisby S; Grebely J; Hajarizadeh B; Martinello M, 2025, 'Prevalence of Injection-Related Bacterial and Fungal Infection Among People Who Inject Drugs: A Systematic Review and Meta-analysis', Open Forum Infectious Diseases, 12, http://dx.doi.org/10.1093/ofid/ofaf108

Reilly C; Mylonakis E; Dewar R; Young B; Nordwall J; Bhagani S; Chia PY; Davis R; Files C; Ginde AA; Hatlen T; Helleberg M; Hayanga A; Jensen TO; Jain MK; Kalomenidis I; Kim K; Lallemand P; Lindegaard B; Menon A; Ognenovska K; Poulakou G; Thorup Røge B; Rogers AJ; Shaw-Saliba K; Sandkovsky U; Trautner BW; Vasudeva SS; Vekstein A; Viens K; Wyncoll J; DuChateau B; Zhang Z; Wu S; Babiker AG; Davey V; Gelijns A; Higgs E; Kan V; Lundgren J; Matthews GV; Lane HC, 2025, 'Evaluation of the Feasibility and Efficacy of Point-of-Care Antibody Tests for Biomarker-Guided Management of Coronavirus Disease 2019', Journal of Infectious Diseases, 231, pp. 677 - 683, http://dx.doi.org/10.1093/infdis/jiae452

Papot E; Tovar-Sanchez T; Woods J; Thaurignac G; Eriobu N; Borok M; Kaplan R; Avihingsanon A; Azwa I; Grinsztejng B; Kumarasamy N; Sokhela S; Mpoudi-Etame M; Arriaga M; Jacoby S; Matthews GV; Losso MH; Khoo S; Calmy A; Kouanfack C; Ayouba A; Petoumenos K; Venter WDF; Delaporte E; Polizzotto MN, 2025, 'SARS-CoV-2 cross-sectional serosurvey across three HIV-1 therapeutic clinical trials in Africa', AIDS, 39, pp. 448 - 456, http://dx.doi.org/10.1097/QAD.0000000000004068

Young C; Singh M; Jackson KJL; Field MA; Peters TJ; Angioletti-Uberti S; Frenkel D; Ravishankar S; Gupta M; Wang JJ; Agapiou D; Faulks ML; Al-Eryani G; Luciani F; Gordon TP; Reed JH; Danta M; Carr A; Kelleher AD; Dore GJ; Matthews G; Brink R; Bull RA; Suan D; Goodnow CC, 2025, 'A triad of somatic mutagenesis converges in self-reactive B cells to cause a virus-induced autoimmune disease', Immunity, 58, pp. 412 - 430.e10, http://dx.doi.org/10.1016/j.immuni.2024.12.011

Nyein PP; Petoumenos K; Borok M; Eriobu N; Kumarasamy N; Avihingsanon A; Azwa I; Dao S; Cisse M; Dharan NJ; Hanson J; Matthews GV, 2025, 'Associations Between Antiretroviral Regimen and Changes in Blood Pressure: Results From the D2EFT Study', Clinical Infectious Diseases, 80, pp. 160 - 163, http://dx.doi.org/10.1093/cid/ciae256

Hage K; Carson J; Hosseini-Hooshyar S; Sacks-Davis R; Stewart AC; Van Santen DK; Smit C; Van Der Valk M; Wittkop L; Klein MB; Doyle JS; Rauch A; Matthews GV; Hellard ME; Boyd A; Prins M, 2025, 'Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies', AIDS, http://dx.doi.org/10.1097/QAD.0000000000004408

Harney BL; Sacks-Davis R; van Santen DK; Stewart AC; Matthews GV; Carson JM; Klein MB; Lacombe K; Wittkop L; Salmon D; Leleux O; Merchadou L; van der Valk M; Smit C; Prins M; Boyd A; Berenguer J; Jarrin I; Rauch A; Hellard ME; Doyle JS, 2025, 'Unsuccessful Direct Acting Antiviral Hepatitis C Treatment Among People With HIV: Findings From an International Cohort', Liver International, 45, pp. 1 - 13, http://dx.doi.org/10.1111/liv.16203

Han WM; Sazzad HMS; Bloch M; Baker DA; Roth N; Bowden-Reid E; Smith DE; Hoy JF; Woolley I; Finlayson R; Templeton DJ; Matthews GV; Costello J; Dawson MA; Dawson SJ; Polizzotto MN; Petoumenos K; Yeh P; Dharan NJ; Winter D; Baker D; Lau H; Acklom K; Price S; O'Bryan J; Sinclair B; Finlayson R, 2024, 'Age-related clonal hematopoiesis and HIV infection are associated with geriatric outcomes: The ARCHIVE study', Cell Reports Medicine, 5, pp. 101835, http://dx.doi.org/10.1016/j.xcrm.2024.101835

Lau DTY; Jackson K; Picchio CA; Kramvis A; Sonderup M; Lemoine M; Matthews G; Howell J; Coffin CS; Hellard M; Lee AU; Anderson DA; Kerth HA; Lee EE; Tavis JE; Dandri M; Revill PA; Spearman CW; Penicaud C; Levrero M; El-Sayed M, 2024, 'Availability of point-of-care HBV tests in resource-limited settings', Lancet Gastroenterology and Hepatology, 9, pp. 1073 - 1076, http://dx.doi.org/10.1016/S2468-1253(24)00308-X

Martinello M; Carson JM; Post JJ; Finlayson R; Baker D; Read P; Shaw D; Bloch M; Doyle J; Hellard M; Filep E; Hosseini-Hooshyar S; Dore GJ; Matthews GV, 2024, 'Control and Elimination of Hepatitis C Virus Among People With HIV in Australia: Extended Follow-up of the CEASE Cohort (2014-2023)', Open Forum Infectious Diseases, 11, http://dx.doi.org/10.1093/ofid/ofae665

Akerman A; Fichter C; Milogiannakis V; Esneau C; Silva MR; Ison T; Lopez JA; Naing Z; Caguicla J; Amatayakul-Chantler S; Roth N; Manni S; Hauser T; Barnes T; Boss T; Condylios A; Yeang M; Sato K; Bartlett NN; Darley D; Matthews G; Stark DJ; Promsri S; Rawlinson WD; Murrell B; Kelleher AD; Dwyer D; Sintchenko V; Kok J; Ellis S; Marris K; Knight E; Hoad VC; Irving DO; Gosbell I; Brilot F; Wood J; Aggarwal A; Turville SG, 2024, 'Cross-sectional and longitudinal genotype to phenotype surveillance of SARS-CoV-2 variants over the first four years of the COVID-19 pandemic', Ebiomedicine, 110, http://dx.doi.org/10.1016/j.ebiom.2024.105415

Phetsouphanh C; Jacka B; Ballouz S; Jackson KJL; Wilson DB; Manandhar B; Klemm V; Tan HX; Wheatley A; Aggarwal A; Akerman A; Milogiannakis V; Starr M; Cunningham P; Turville SG; Kent SJ; Byrne A; Brew BJ; Darley DR; Dore GJ; Kelleher AD; Matthews GV, 2024, 'Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection', Nature Communications, 15, pp. 3315, http://dx.doi.org/10.1038/s41467-024-47720-8

Hume SJ; Wong DK; Yuen MF; Jackson K; Bonanzinga S; Vogrin S; Hall SAL; Burns GS; Desmond PV; Sundararajan V; Ratnam D; Levy MT; Lubel JS; Nicoll AJ; Strasser SI; Sievert W; Ngu MC; Sinclair M; Meredith C; Matthews G; Revill PA; Littlejohn M; Bowden S; Visvanathan K; Holmes JA; Thompson AJ, 2024, 'High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy', Liver International, 44, pp. 2605 - 2614, http://dx.doi.org/10.1111/liv.16029

Tillakeratne S; Pearson SA; Alavi M; Hajarizadeh B; Martinello M; Law M; George J; Amin J; Matthews G; Grebely J; Dore GJ; Valerio H, 2024, 'Trends in viral hepatitis liver-related morbidity and mortality in New South Wales, Australia', Lancet Regional Health Western Pacific, 51, http://dx.doi.org/10.1016/j.lanwpc.2024.101185

Back to profile page